Early research on T2DM suggested that TZDs lower hyperglycemia and hyperinsulinemia levels while increasing insulin sensitivity in the liver, adipose tissue, and skeletal muscle [5,6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.